InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.13
(
0.09%
)
US TECH 100
18,176.00
(
-0.11%
)
Dow Jones
39,806.77
(
-0.49%
)
Brent Oil
82.96
(
-0.69%
)
Bitcoin
70,897.48
(
-0.77%
)
Post# of 44175
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Gonzal

Send PM Follow Ignore
Followers 3
Posts 572
Boards Moderated 0
Alias Born 08/27/2020

Gonzal

Re: Gonzal post# 43860

Friday, 02/16/2024 1:37:55 PM

Friday, February 16, 2024 1:37:55 PM

Post# of 44175
https://www.acrobiosystems.com/L-1666-CD56.html?gad_source=1&gclid=EAIaIQobChMIibSKjb-whAMVczrUAR3DbA-BEAAYASAAEgJGWfD_BwE

Name Research Code Research Phase Company Indications Clinical Trials

Lorvotuzumab mertansine BB-10901; IMGN-901; huN-901-DM1; IMGN-901-TAP; huN-901-SPP-DM1 Phase 2 Clinical Immunogen Inc Ovarian Neoplasms; Leukemia; Rhabdomyosarcoma; Carcinoma, Merkel Cell; Small Cell Lung Carcinoma; Wilms Tumor; Multiple Myeloma; Sarcoma, Synovial; Neurofibrosarcoma; Neuroblastoma; Carcinoma, Small Cell

Details

GD2/CD56 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute) bi-4SCAR GD2/CD56 Phase 2 Clinical Shenzhen Geno-Immune Medical Institute Neoplasms

Details

CUBT-906 CUBT-906 Phase 2 Clinical Curative Biotechnology Inc
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CUBT News
More CUBT News
InvestorsHub NewsWire

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!